Arrowstreet Capital’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.2K Hold
17,204
﹤0.01% 1887
2026
Q1
$39.1K Hold
17,204
﹤0.01% 1809
2025
Q4
$51.8K Hold
17,204
﹤0.01% 1806
2025
Q3
$63.8K Hold
17,204
﹤0.01% 1823
2025
Q2
$68.5K Hold
17,204
﹤0.01% 1910
2025
Q1
$82.6K Hold
17,204
﹤0.01% 1768
2024
Q4
$88.6K Hold
17,204
﹤0.01% 1691
2024
Q3
$128K Buy
+17,204
New +$135K ﹤0.01% 1674
2016
Q3
Sell
-32,600
Closed -$518K 1536
2016
Q2
$518K Buy
32,600
+11,398
+54% +$201K ﹤0.01% 1135
2016
Q1
$536K Sell
21,202
-24,316
-53% -$747K ﹤0.01% 1109
2015
Q4
$1.48M Buy
45,518
+442
+1% +$16.5K 0.01% 879
2015
Q3
$1.59M Buy
45,076
+17,573
+64% +$793K 0.01% 805
2015
Q2
$1.64M Sell
27,503
-2,827
-9% -$190K 0.01% 688
2015
Q1
$2.37M Buy
30,330
+12,492
+70% +$966K 0.01% 570
2014
Q4
$1.38M Buy
17,838
+14,332
+409% +$937K 0.01% 815
2014
Q3
$223K Hold
3,506
﹤0.01% 928
2014
Q2
$252K Sell
3,506
-16,936
-83% -$1.31M ﹤0.01% 901
2014
Q1
$1.81M Sell
20,442
-8,372
-29% -$652K 0.01% 678
2013
Q4
$2.25M Buy
+28,814
New +$2.35M 0.01% 632

Other funds holding HHS

Arrowstreet Capital's HHS Position: Q2 2026 in Review

Arrowstreet Capital held its Harte-Hanks (HHS) position steady in Q2 2026 at 17,204 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1887.

Arrowstreet Capital first reported a position in HHS in Q4 2013 and has held it in 19 quarters since. The position peaked at $2.37M in Q1 2015. 22 funds tracked by Wall St. Rank hold HHS as of Q2 2026.

  • Arrowstreet Capital held 17,204 shares of Harte-Hanks worth $37.2K as of Q2 2026.
  • Arrowstreet Capital left its Harte-Hanks share count unchanged in Q2 2026.
  • Harte-Hanks made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1887 holding.
  • Arrowstreet Capital first reported a position in Harte-Hanks in Q4 2013 and has held it in 19 quarters since.
  • Arrowstreet Capital's Harte-Hanks position peaked at $2.37M in Q1 2015.
  • 22 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.